A standardized protocol and team approach for CT-guided lung needle biopsy optimizes the ability to achieve a high accurate diagnostic yield with adequate tissue for molecular testing.
Many CT-guided biopsies for the diagnosis of lung lesions occur in the community hospital setting. However, limited reports have evaluated the success of this procedure outside large tertiary medical centers. Our aim is to report our overall experience with the use of a standardized team-based protocol for procuring, processing, and diagnosing CT-guided lung biopsies with particular concentration on NSCLC. In this retrospective observational study of CT-guided lung biopsies at a single community hospital, we evaluated diagnostic yield, diagnostic accuracy, and adequacy of tissue samples for requested molecular testing.
Methods
The present study was conducted in a general 229-acute bed community hospital located in southeast Florida.
The radiology department has 1 full-time interventional radiologist and 2 full-time pathologists. Many of the patients were outpatient referrals from community physicians, and the remainder were inpatients usually admitted for other reasons. This study was exempt from institutional review board approval. there was insufficient tissue to subclassify the NSCLC further, NSCLC, not otherwise specified, was rendered.
Statistical Analysis
Data were summarized using descriptive statistics.
The calculations used the formulas below.
(1) Sensitivity of the overall procedure (S op , benign and malignant) was calculated as: was calculated using the following equation:
where PM fb is the number of all cases diagnosed as malignant on the first biopsy and ATM is the number of all true malignant cases. were true benign nonspecific cases. In the present study, the diagnostic accuracy, negative predictive value, and sensitivity of CT-guided lung biopsies for malignant lesion was 95%, 80%, and 94%, respectively ( Table 4) . The sensitivity and diagnostic accuracy of the overall procedure (benign and malignant) was 95% and 94%, respectively.
Molecular Studies
In 25 cases, molecular studies were requested and CNB paraffin-embedded tissue was used in all cases. 
Initial CT-Guided Biopsy Results
The breakdown of the 216 initial biopsy cases by diagnostic category and sex is detailed in The 216 initial biopsies were further divided into a diagnostic success group and a failure group. The biopsy was diagnostically successful in 189 of 216 (88%) cases. Of these cases, 154 (81%) were malig-
Discussion
The present study evaluated diagnostic yield, diagnostic accuracy, and adequacy of tissue samples for requested molecular testing of a team-based protocol for procuring, processing, and diagnosing CT-guided lung biopsies, with particular concentration on NSCLC.
Diagnostic Yield
The overall accuracy (benign and malignant) of 94%, and diagnostic sensitivity, accuracy, and negative predictive value for malignant lesion of 94%, 96%, and 80%, respectively, are within the range reported in the literature. [5] [6] [7] [8] In a study of 226 CT-guided lung CNBs, The results of the present study are in keeping with those of previous studies, [5] [6] [7] [8] 11 indicating that CT-guided biopsies have a relatively high false-negative rate for the diagnosis of malignant lesion. In the present study, 9 of 13 (69%) unsuccessful cases that had subsequent biopsy sampling represented missed cancers. Gelbman et al 11 reported 170 patients who underwent a CT-guided FNA Large consolidative mass-like density extending from the CT scan 3 wk later showed decrease in size of the right lateral right hilum to the right anterior and lateral chest walls involving lung mass and clearing of the diffuse infiltrates that were present the right middle and upper lobes, measuring approximately in the right upper and right middle lobe previously; patient was 14.6×9.0 cm with diffuse mediastinal, hilar, and subcarinal discharged from hospital with a diagnosis of pneumonia adenopathy, large areas of air bronchograms, thickening of the interlobular septa, and crazy paving appearance; these findings, sometimes seen with severe pneumonia, are worrisome for malignancy with lymphangitic carcinomatosis
39
Right upper lobe nodular density (12 mm The benign nonspecific group included cases in which the initial CT-guided biopsy results showed nonspecific tissue changes, such as chronic inflammation, fibrosis, or acute pneumonia, and the clinical presentation or radiological images at the time of the procedure were non-contributory. Although the imaging for case 222 was reported highly suspicious for malignancy, follow-up confirmed that this represented an overcall by radiology, and the case was therefore classified with the benign nonspecific group.
Abbreviation: CT, computed tomography. A limited number of prior studies discuss the ability to subclassify NSCLCs into adenocarcinoma, squamous cell carcinoma, or a mixed carcinoma with an adenocarcinoma component using small biopsies, partly because Although the initial CT biopsy was suspicious for lymphoma, this case was classified in the nondiagnostic category because the tissue was insufficient for definitive diagnosis.
Abbreviations: NA, not applicable; CT, computed tomography; NSCLC, nonsmall cell lung cancer.
CNB cases, even though we did not specifically assess these parameters in this study.
Adequacy of Tissue for Molecular Studies
Although it can be challenging to acquire adequate and 6%, respectively. 12 However, when both cytology and biopsy paired specimens were combined, the rate of definitive diagnoses by at least 1 method was increased to 84%, and the unclassified rate decreased to 4%. 12 The authors concluded that optimal results are attained when the 2 modalities are considered jointly.
12
Similar to Sigel et al, 12 we successfully subclassified 86% of the NSCLC cases in the present study and favored a subtype in an additional 8% of cases. In addition, 6% of our NSCLC cases were unclassifiable (NSCLC, not otherwise specified). We believe the use of immunostains along with the combined use of cytology on the TP slides and histomorphology substantially increased our ability to subtype our NSCLC 
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Limitations
The present study had several limitations. A major limitation is the lack of availability of outcome data from the patients without follow-up in the nondiagnostic and be- Finally, the data collected are from 1 center, which makes generalization more difficult.
Conclusions
The results of the present study show that CT-guided percutaneous lung needle biopsy in a community hospital setting can achieve a high accurate diagnostic yield with adequate tissue for molecular and other ancillary testing.
We attribute our success to having a team composed of radiologists, pathologists, clinicians, and laboratory specialists who are dedicated to optimizing the procurement, processing, and diagnosis of cases. We approach each case as if ancillary studies might be required. The radiologist is always prepared to obtain additional tissue for such studies when the onsite pathologic evaluation shows that it might be indicated. Staff at the histology laboratory are careful to conserve tissue using proactive cutting procedures, and the pathologist is careful not to waste tissue by doing unnecessary immunostains. The literature emphasizes that this type of team approach is optimal for obtaining sufficient material, 4,21 and our results support this finding.
